Evidence map›Paper›PMID 37706628›Full record

ArticleCancer medicine2023

Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer.

Zi-Yao Jia, Yi-Di Zhu, Xiang-Song Wu, Jing-Xiao Yang, Wen-Guang Wu, Xu-An Wang, Min He, Hui Wang, Lin-Hua Yang, Jie Zhang and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. New trends in diagnosis and management of gallbladder carcinoma.World journal of gastrointestinal oncology · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Zi-Yao JiaDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yi-Di ZhuShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Xiang-Song WuShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Jing-Xiao YangDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wen-Guang WuDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xu-An WangDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Min HeDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hui WangDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lin-Hua YangDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jie ZhangDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xue-Chuan LiDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lu ZouDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Huai-Feng LiShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Fei ZhangShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Run-Fa BaoShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Xu-Ya CuiDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiao-Ling SongShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.
Wei ChenDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wei GongShanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.ORCID 0000-0002-9949-6207
Mao-Lan LiDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ying-Bin LiuDepartment of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0001-6110-0185
Shanghai Jiao Tong University · CN

Funding

Shanghai Clinical Medical Research Center for Digestive Diseases 19MC1910200Shanghai Municipal Health Commission health Industry clinical research special project 20224Z0014the Basic Research Project of Science and Technology Commission of Shanghai Municipality 20JC1419100the Basic Research Project of Science and Technology Commission of Shanghai Municipality 20JC1419101the Basic Research Project of Science and Technology Commission of Shanghai Municipality 20JC1419102the Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center SHDC12019110the National Key Research and Development Program of China 2021YFE0203300the National Natural Science Foundation of China 82073206the Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission 20SG14
6 · The paper itself

Abstract

backgroundThree-dimensional visualization preoperative evaluation (3D-VPE) and enhanced recovery after surgery (ERAS) have been suggested to improve outcomes of cancer surgery in patients, yet little is known regarding their clinical benefit in patients with gallbladder cancer (GBC). We hypothesized that the combination of 3D-VPE and ERAS would improve the outcome of patients undergoing surgery for GBC.

objectiveThis study aimed to determine if 3D-VPE and ERAS can improve the outcomes and overall survival in patients with GBC, establishing a novel patient management strategy for GBC.

methodsA total of 227 patients with GBC were recruited and divided into two groups: those who received traditional treatment between January 2000 and December 2010 (n = 86; the control group) and those who underwent 3D-VPE and ERAS between January 2011 and December 2017 (n = 141). Univariate and multivariate analyses were employed to assess the relationship among disease stages, lymph node invasion, and cell differentiation between the two groups. Cox regression analysis was used to investigate patient survival in these groups.

resultsPatients who underwent 3D-VPE and ERAS showed a significantly higher R0 resection rate (67.4% vs. 20.9%, p < 0.001) and dissected lymph node number (26.6 ± 12.6 vs. 16.3 ± 7.6 p < 0.001) compared to the control group. The median survival was 27.4 months, and the 1- and 3-year survival rates were 84.4% and 29.8%, respectively, in patients who received combined management; in the control cohort, the median survival was 12.7 months, and the 1- and 3-year survival rates were 53.5% and 15.1%, respectively. In addition, some postoperative complications and risk factors were diminished relative to the traditionally treated patients.

conclusionThe implementation of 3D-VPE and ERAS can significantly improve the prognosis and outcomes of patients with GBC and should be considered for wide use in clinical practice.

Indexed as

Gallbladder NeoplasmsImaging, Three-DimensionalPreoperative CareAdultAgedEnhanced Recovery After SurgeryFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesTreatment Outcome3D visualization preoperative evaluationenhanced recovery after surgerygallbladder cancer

Identifiers

PMID37706628
PMCPMC10557873
OpenAlexW4386726820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.